CBI’S 17TH ANNUAL PHARMACEUTICAL COMPLIANCE CONGRESS: DOJ and SEC Insights
CBI’s annual Pharmaceutical Compliance Congress is the world’s largest event for compliance and legal professionals in the bio/pharma industry. This year, Partner Gary Giampetruzzi, Global Chair of the Life Sciences Practice, will moderate a panel discussion about recent DOJ and SEC Insights impacting the Life Sciences sector.
Moderator:Gary GiampetruzziPartner, Litigation DepartmentPaul Hastings LLP
Robert DodgeAssistant Director, FCPA Unit,U.S. Securities and Exchange Commission (SEC)
Gustav EylerDirector, Consumer Protection BranchU.S. Department of Justice (DOJ)
Joseph BeemsterboerSenior Deputy Chief at Fraud Section, Criminal DivisionU.S. Department of Justice (DOJ)